Clinical Trials on Hodgkin Disease Refractory
Total 380580 results
-
Fondazione Italiana Linfomi ONLUSIstituto Clinico HumanitasTerminated
-
Cancer Institute WIACompleted
-
Centre Hospitalier Universitaire DijonThe Lymphoma Study AssociationCompleted
-
Gemin XCompletedHodgkin's LymphomaUnited States
-
National Cancer Center, KoreaAsan Medical Center; Severance HospitalUnknownHodgkin's LymphomaKorea, Republic of
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)WithdrawnHIV Infection | Recurrent Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | AIDS-Related Non-Hodgkin Lymphoma | AIDS-Related Hodgkin LymphomaUnited States
-
Stanford UniversityThe Leukemia and Lymphoma Society; Biospect IncRecruitingLymphoma, Non-Hodgkin | Hodgkin's DiseaseUnited States
-
University of RochesterCompletedLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
Merck Sharp & Dohme LLCCompletedNeoplasms | Lymphoma, Non-Hodgkin | Hodgkin Disease
-
Pharmacyclics LLC.CompletedLymphoma | Lymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
King Faisal Specialist Hospital & Research CenterUnknownLymphoma, Non-Hodgkin | Hodgkin DiseaseSaudi Arabia
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedLymphoma, Non-Hodgkin | Hodgkin's DiseaseCanada
-
Shanghai General Hospital, Shanghai Jiao Tong University...RecruitingRefractory Lymphoma | Refractory Leukemia | Efficacy, Self | T-lymphoblastic Lymphoma | Safety | Relapsed DiseaseChina
-
Greg MonohanTerminatedMultiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States
-
Institut Paoli-CalmettesCompletedHodgkin Lymphoma | Acute Leukemia | Non-hodgkin Lymphoma | Malignant HaemopathiesFrance
-
University of WashingtonBristol-Myers SquibbActive, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Refractory Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma and other conditionsUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingRecurrent and Refractory Non-Hodgkin's Lymphoma and Multiple MyelomaChina
-
Acrotech Biopharma Inc.CompletedB-cell Lymphoma | Hodgkin's Lymphoma | Relapsed or Refractory Lymphoproliferative Malignancies | Peripheral T-cell Lymphoma | Waldenstrom's MacroglobulinemiaUnited States
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Follicular Lymphoma | Relapsed/Refractory Large B Cell LymphomaUnited States
-
WiSP Wissenschaftlicher Service Pharma GmbHLudwig-Maximilians - University of Munich; Chugai Pharma GmbHCompletedHodgkin's Disease | Non-Hodgkin Lymphomas | Multiple Myelomas
-
Novartis PharmaceuticalsCompletedClassical Hodgkin's LymphomaSpain, France, Belgium, Italy, Israel, Germany, United States, Australia, Brazil, Singapore, Malaysia, New Zealand, United Kingdom
-
David Bond, MDRecruitingRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent... and other conditionsUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Active, not recruitingLymphoma | Lymphoma, Non-Hodgkin | Relapse | Hodgkin's DiseaseUnited States
-
National Cancer Institute (NCI)Children's Oncology GroupRecruitingMalignant Solid Neoplasm | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Ependymoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Glioma | Recurrent Malignant Solid Neoplasm | Recurrent... and other conditionsUnited States, Puerto Rico, Australia
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Childhood Medulloblastoma | Recurrent Childhood Ependymoma | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Glioma | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma and other conditionsUnited States, Puerto Rico
-
St. Jude Children's Research HospitalParexel; Jazz PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Non Hodgkins LymphomaUnited States
-
TakedaCompletedHodgkin Disease | Lymphoma, Large-Cell, AnaplasticChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | CD19 PositiveUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni FoundationCompletedDiffuse Large B-Cell Lymphoma | Acute Myeloid Leukemia | Refractory Hodgkin Lymphoma | Previously Treated Myelodysplastic Syndrome | Recurrent Mantle Cell Lymphoma | Waldenstrom Macroglobulinemia | Acute Lymphoblastic Leukemia | Refractory Plasma Cell Myeloma | Recurrent Small Lymphocytic Lymphoma | Refractory... and other conditionsUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingNeoplasms | Immune System Diseases | Neoplasms by Histologic Type | Lymphoma | Lymphoproliferative Disorders | Lymphatic Diseases | Immunoproliferative Disorders | Lymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
University Hospital, Clermont-FerrandCompletedLymphoma, Non-Hodgkin | Hodgkin Disease | Young AdultsFrance
-
GPCR Therapeutics, Inc.CompletedMultiple Myeloma | Non-hodgkin's Lymphoma | Hodgkin's DiseaseUnited States
-
New York Medical CollegeJohns Hopkins University; M.D. Anderson Cancer Center; Baylor College of Medicine and other collaboratorsCompletedNon-Hodgkins Lymphoma | Lymphoproliferative Disorder | Hodgkins LymphomaUnited States
-
Peking UniversityPeking University Cancer Hospital & InstituteRecruitingB Cell Non-Hodgkin's LymphomaChina
-
Peking University People's HospitalNot yet recruitingT-cell Non-Hodgkin's Lymphoma
-
Peking UniversityUnknownB-cell Non-Hodgkin's Lymphoma
-
Genzyme, a Sanofi CompanyCompletedLymphoma | Multiple Myeloma | Non Hodgkin's Lymphoma | Hodgkin's DiseaseGermany
-
Hrain Biotechnology Co., Ltd.Shanghai Zhongshan HospitalRecruitingB-cell Non-Hodgkin's LymphomaChina
-
Nanjing IASO Biotherapeutics Co.,LtdNot yet recruitingB-cell Non-Hodgkin's Lymphoma
-
Kyowa Kirin Co., Ltd.Active, not recruitingStudy of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)Indolent B-cell Non-Hodgkin's LymphomaJapan
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Worldwide Clinical TrialsSuspendedB-cell Non-Hodgkin's LymphomaUnited States
-
CelgeneTerminatedT-cell Non-Hodgkin's LymphomaFrance, United States, Australia, Belgium
-
SandozNovartis PharmaceuticalsCompletedIndolent B-cell Non-Hodgkin's LymphomaJapan
-
NCIC Clinical Trials GroupEastern Cooperative Oncology GroupCompletedHodgkin LymphomaCanada, United Kingdom, Italy
-
SanofiCompletedLymphoma | Non-HodgkinUnited States
-
Seagen Inc.TerminatedFollicular B-cell Non-Hodgkin's Lymphoma | Diffuse Large B-cell Lymphoma RefractoryUnited States, Italy, Spain, United Kingdom, Czechia, Poland, France
-
S*BIOCompletedLymphoma, Malignant | Hodgkin's Lymphoma | B Cell LymphomaUnited States
-
TakedaCompletedUntreated CD30-Positive Hodgkin's LymphomaJapan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)UnknownRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Recurrent Acute Lymphoblastic Leukemia and other conditionsUnited States